Company: SWKH
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001628280-25-025955
Chunk: 76

Company: SWK Holdings Corp
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 76
---
ings Company and other24,290 25,201 Total$331,264 $332,235 

22

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided as a supplement to, and should be read in conjunction with, our audited consolidated financial statements, and the MD&A included in our Annual Report on Form 10-K for the year ended December 31, 2024 (“Annual Report”), as well as our unaudited condensed consolidated financial statements and the accompanying notes included in this report.

Overview 

We have organized our operations into two segments: Finance Receivables and Pharmaceutical Development. These segments reflect the way the Company evaluates its business performance and manages its operations. Please refer to Item 1. Financial Statements, Note 9 of the notes to the unaudited condensed consolidated financial statements for further information regarding segment information.

23

Finance Receivables Portfolio Overview

The table below provides an overview of our outstanding finance receivables transactions as of and for the three months ended March 31, 2025 (in thousands, except rate, share and per share data):

Revenue RecognizedRoyalty PurchasesLicensed TechnologyFunded AmountGAAP BalanceYear-to-DateBesivance® (1) Ophthalmic antibiotic$6,000 $— $2 Forfivo XL® (7)Depressive disorder treatment6,000 1,110 506 Coflex®/Kybella® (7)Spinal stenosis/submental fullness4,350 2,702 48 Cambia® (4) (7)NSAID migraine treatment8,500 — 98 Duo Royalty (7)Japanese Women's health/cystic fibrosis15,353 10,083 591 Immune Globulin (7)Immune Globulin Therapeutics 14,100 10,452 443 Relief (7)Rare Disease Portfolio7,701 7,331 336 Best ABT, Inc.(2), (3)Oncology diagnosis 5,784 2,347 — Flowonix Medical, Inc.(2), (3), (5)Drug delivery device 12,455 7,433 — Ideal Implant, Inc.(2), (3)Aesthetics 4